Robert Ross Carter - 17 Mar 2026 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Issuer symbol
TOI
Transactions as of
17 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 17:20:19 UTC
Previous filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carter Robert Ross Chief Financial Officer C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD #800, CERRITOS /s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter 18 Mar 2026 0002039341

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Other -1,314 -0.56% $3.59* 233,811 17 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026.